NCT04082676View on ClinicalTrials.gov

Height Versus Height and Weight Based Spinal Bupivacaine on Maternal Haemodynamics for Elective Cesarean in Short Stature Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Maternal Hypotension After Spinal Anesthesia
Interventions
DRUG

Hyperbaric bupivacaine spinal

In this group patient will receive intrathecal hyperbaric bupivacaine based on patients height and weight according to Harten chart with 10 μg of fentanyl (0.1 ml)

DRUG

Hyperbaric bupivacaine spinal

In this group will receive intrathecal hyperbaric bupivacaine based on patients height (0.06mg/cm) with 10 μg of fentanyl (0.1 ml)

Trial Locations (1)

56700

BP Koirala Institute of Health Sciences (BPKIHS), Dharān

All Listed Sponsors
lead

B.P. Koirala Institute of Health Sciences

OTHER

NCT04082676 - Height Versus Height and Weight Based Spinal Bupivacaine on Maternal Haemodynamics for Elective Cesarean in Short Stature Patients | Biotech Hunter | Biotech Hunter